Derya Tilki, MD
@Tilki_De
Followers
1K
Following
1K
Media
0
Statuses
179
Urologist at Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf | Associate Editor @EurUrolFocus
Joined September 2015
#ESMO25 Discussant – #EMBARK and #PRESTO Trials. Presentation by @Tilki_De @MartiniKlinik. Written coverage by @RKSayyid @UAUrology on UroToday > https://t.co/yz2YILBO0d
@myESMO
1
7
18
0
3
10
#ESMO25 will be a fantastic meeting for GU oncology! Join us to discuss 5 impactful phase 3 trials #ProstateCancer @myESMO
2
14
37
I'm thrilled to be able to share this report from the symposium CAncer or Not Cancer?: Evaluating and Reconsidering GG1 prostate cancer (CANCER-GG1?), out today @JNCI_Now When is prostate cancer really cancer?
academic.oup.com
Abstract. Prostate cancer (PC) is a major cause of cancer-related deaths worldwide, with far more diagnoses than deaths annually. Recent discussions have c
6
15
55
The summary paper (part II) of the EAU PCa guidelines is now available online. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer. @philcornford @EUplatinum @Uroweb
https://t.co/8CBkXikmck
4
3
30
The latest version of the prostate cancer guidelines are now summarised and available. You have heard the rumours now read what we changed and why! @EUplatinum @Uroweb @Tilki_De
2
23
68
🗓️As the hybrid #APCCC24 swiftly approaches with its start date of April 25th, we're eager to revisit Session 2, focusing on the critical areas of Biochemical Recurrence and PSA Persistence in prostate cancer. Derya Tilki and Thomas Zilli skillfully guide this session in Part
0
5
5
Prostate cancer cases are expected to double from 1.4 million per year in 2020 to 2.9 million per year by 2040, new analysis suggests. More from the Lancet Commission on #ProstateCancer in-thread 🧵 ▶️ https://t.co/r1VhQobHKR
14
153
247
Hot debate on role of ePLND for #prostatecancer in context of -ve PSMA-PET at #EAU24 plenary @declangmurphy vs @delataillealex - @Uroweb guidelines updated: stronger recommendation for use of PSMA-PET to stage & weaker for ePLND
0
5
18
🌟 Be part of a pivotal moment in advanced #prostatecancer managment at #APCCC24! Join global experts in consensus discussions that shape future treatments. 🗓️ Register now for an unmissable experience: https://t.co/eFBFJWiXha
#Oncology #GU24 #oncoalert
1
10
23
🔍 Session 2 of #APCCC24 delves into Treatment for Biochemical Recurrence/PSA Persistence, featuring leading experts in the field. Chaired by @ZilliThomas and @Tilki_De in Part 1 and Jason Efstathiou and @BarbaraJereczek in Part 2, the session includes additional insightful
0
4
11
Thanks @Tilki_De @urotoday for great summary on BCR 🙏🏻 Thanks ++ for highlighting our @ANZUPtrials #DIPPER trial, coord @georgeinstitute Open in multiple sites around Australia incl @MetroNorthHHS #stvincentssydney @PeterMacRadOnc @pros_tic #GenesisCareAU (+soon Int’l sites)
Setting the stage: Biochemical recurrence after local treatment for #ProstateCancer. Presentation by @Tilki_De @MartiniKlinik. #GU24 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/hTzlnktVmN
@ASCO
1
7
13
Setting the stage: Biochemical recurrence after local treatment for #ProstateCancer. Presentation by @Tilki_De @MartiniKlinik. #GU24 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/hTzlnktVmN
@ASCO
0
12
31
#GU24 #ASCOEdBook chapter: Emerging possibilities to de-escalate treatment in #ProstateCancer: https://t.co/4aqLuKs414
@KOSJ12 @Tilki_De #pcsm #gucsm
1
4
7
🔬 The upcoming APCCC 2024 session 2 delves into the critical topic of Treatment for Biochemical Recurrence/PSA Persistence in prostate cancer. Expect in-depth discussions with @Tilki_De @ZilliThomas @BarbaraJereczek @BertrandTOMBAL @DrSpratticus Jason Efstathiou @DrPaulNguyen
1
7
25
You want to learn about prostate cancer ? No better place to go: APCCC 2024 in Lugano! Register here ! https://t.co/ZFxDiOy0dP
@APCCC_Lugano @Silke_Gillessen @AOmlin @amerseburger @Tilki_De @stefanofanti4 @DrMHofman
1
8
26
Meet some of the esteemed chairs of #APCCC24, driving forward the conversation in advanced #prostatecancer. Connect with the forefront of oncology leadership. Visit now: https://t.co/fD5boXN3ZB
#OncologyLeaders @AOmlin @Silke_Gillessen @Tilki_De @NehaVapiwala @nealshore
0
3
10
Just finished developing the first draft of questions for 2024. As @BertrandTOMBAL put it: THE unique moment of intense cogitation on where we stand on advanced prostate cancer. If you want to be a part of it register now for @APCCC_Lugano at
apccc.org
🤔 Tackling tough questions in advanced #ProstateCancer? Get answers at #APCCC24, April 25-27 in Lugano🇨🇭 Sign up today: https://t.co/eFBFJWiXha Where the future of #ProstateCancer management is shaped. #ProstateCancerAwareness #ConsensusConference
#Oncology #RegisterNow
0
13
34
Happening now… Vip Patel using the Edge Medical robot on a patient in Harbin, China. But he is 1200km away in Beijing! Zero latency. Looks like a Da Vinci S HD #telesurgery #roboticsurgery @gu_onc
8
45
183
Ein schönes C-E. Alken-Treffen 2023 in Hamburg geht zu Ende - schön, dass Pailin ihre „Growing Teratoma“-Studie vorstellen durfte und herzlichen Glückwunsch @JLinxweiler zum wohlverdienten Alken-Preis!
0
2
14